Imaginez un médecin dans une clinique esthétique ou un centre de perte de poids qui passe plusieurs minutes par ordonnance à faxer, appeler et attendre des confirmations de prix. Multipliez cela par des dizaines d’ordonnances quotidiennes et vous obtenez des heures perdues chaque jour, des patients frustrés et une croissance limitée. C’est précisément ce problème […]
The post VITL Révolutionne…
Customers have complained that a telehealth network selling compounded GLP-1s has been ripping them off—even after it had to pay $5 million to clients as part of a settlement with the US government.
Novo Nordisk's CEO says the company’s blockbuster obesity drugs could ultimately pull it into increasingly buzzy areas of healthcare, from longevity research to aesthetic medicine.
Oura Ring 5 arrives with a smaller design, AI-powered health monitoring, blood pressure tracking, breathing insights, and improved fitness features.
There are more than 1,300 Smoothie King locations worldwide
Signos secures backing from Google Ventures, Dexcom and BCBS of Alabama to scale its CGM and AI coaching platform for weight management.
歐洲藥品管理局CHMP建議核准諾和諾德Wegovy兩款新劑型：7.2毫克單劑量注射筆與口服錠。此舉旨在簡化成人肥胖症體重管理療程、提升用藥便利性，預計2026年起陸續上市。
Health Canada approved both Dr. Reddy's and Apotex's generic semaglutide — the active ingredient in brand-name Ozempic — about three weeks ago.
GLP-1 類藥物用於減重時，觀測到顯著的肌肉量流失副作用，可能導致肌少症風險及代謝率下降。為緩解此效應，建議應搭配阻力訓練。目前缺乏停藥指引，需更多研究釐清對不同族群的全面影響。
A new study reveals a surprising social penalty for using GLP-1 weight-loss medications.
Patients can receive the treatments at home for 'no additional cost' and will have the option of chatting with a pharmacist over the phone, Novo Nordisk said.
While improved health awareness and aging populations have also boosted whey prices, the GLP-1 trend is the key factor behind demand.
The post Weight-Loss Drugs Fuel Protein-Rich Whey Craving appeared first on Athletech News.
BY THE OPTIMIST DAILY EDITORIAL TEAM A study presented at the 2026 American Academy of Orthopaedic Surgeons annual meeting found that among nearly 147,000 adults with type 2 diabetes and obesity, GLP-1 use was associated with higher rates of osteoporosis, osteomalacia, and gout. The finding attracted a lot of attention, but the fine print matters […]
The post What doctors want you to know about…
Niagen Bioscience is launching at-home NAD+ precursor injection kits as GLP-1s normalize consumer comfort with self-administered shots.
The post Niagen Bioscience Enters Telehealth With At-Home NAD+ Precursor Injection Kits appeared first on Athletech News.
Forbes, a mais conceituada revista de negócios e economia do mundo.
Em nova revisão clínica, guiada pela Universidade Anglia Ruskin, medicamentos análogos ao GLP-1 mostraram resultados efetivos no tratamento
O post Canetas Emagrecedoras Podem Reduzir Acúmulo de Proteínas Associadas Ao Alzheimer, Aponta Estudo apareceu primeiro em Forbes Brasil.
The online platform’s Art Break feature helps users carve out regular moments of mindfulness, no matter where they are in […]
The post How Noom Is Using Art Therapy to Power Its Whole-Body Approach to Health & Wellness appeared first on Athletech News.
Eli Lilly’s once-daily Foundayo is the second obesity pill to receive FDA approval. It will compete with Novo Nordisk’s pill version of Wegovy.
Researchers launched a startup to turn a bizarre snake metabolite into the ultimate weight loss drug.
Contributed by Amanda DeVries
_**Source: www.eyecandydesign.co **Andrew Wyton. License: All Rights Reserved. _
Tide Treats is a portion-conscious, protein-packed snack bar created specifically for people using GLP-1 medications.
With a satisfying crunch, thoughtful formulation, and bold, modern branding, it’s designed to support appetite shifts without compromise – helping users ride the…
減重藥物成分「司美格魯肽」於印度專利到期。本土仿製藥將大幅降低藥價，提升肥胖與糖尿病患者的用藥可及性，但也引發品質監管與濫用疑慮。此舉預期將衝擊全球市場。
Registered dietitian Sahar Berjis and other experts weigh in on the supplements that help address the nutrition gap and other […]
The post The Best Supplements for GLP-1 Users, According to Nutritionists appeared first on Athletech News.
Por Redação
O post Patente do Ozempic cai nesta sexta-feira (20); entenda apareceu primeiro em Todo Dia.
Me gustó mucho cómo La Hiperactina explicó la ciencia que hay detrás del Ozempic, más que nada porque su tono divulgativo me parece absolutamente ideal (por no hablar de sus comillas aereas. Desde 2017, fecha en que se aprobó para adultos en Estados Unidos, el Ozempic (nombre comercial de la semaglutida) ha sido uno de los médicamente más mitificados y comentados, por su famoso «efecto…
The unlikely journey starts with the "Gila monster".
Compounding pharmacies are illegally selling GLP-1 drugs, and the FDA is determined to shut that pathway down.
The post Generic GLP-1s are coming, but Americans don’t want to wait first appeared on Science-Based Medicine.
鑒於代謝功能異常相關脂肪性肝炎（MASH）之心血管與肝癌高風險，台灣已核准首款GLP-1類藥物。此療法可緩解肝炎並改善代謝指標，呼籲民眾應及早診斷、積極介入，建立正確治療觀念。
There is a lot of nonsense out there on social media about GLP-1 agonists, the popular pills that help diabetics and are increasingly prescribed for weight loss. I’m using the word nonsense here in its formal medical sense, to mean social media histrionics that aren’t backed up by any kind of decent studies. That said, […]
The post A Pill To Kill The Love appeared first on ErosBlog.
After years of “gym as a clinic” hype, operators like UFC Gym and Planet Fitness are finally making moves to offer their members access to GLP-1s.
The post ATN Weekly: Gyms Are Riding the GLP-1 Wave appeared first on Athletech News.
Planet Fitness CEO Colleen Keating sees a significant and largely untapped membership base taking shape as more people take GLP-1s.
The post Planet Fitness Points To GLP-1 Opportunity as Outlook Rattles Investors appeared first on Athletech News.
The psychology-based platform’s new Microdose GLP-1Rx Program is affordable and is designed to be easy on your body.
The post How Noom’s GLP-1 Programs Are Designed for Long-Term Health appeared first on Athletech News.